{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:46:51Z","timestamp":1782805611728,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ygyno.2017.12.019","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T20:46:04Z","timestamp":1513802764000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-0746","authenticated-orcid":false,"given":"Shuangshuang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lairson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyaw","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Ramondetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.12.019_bb0005","author":"U.S. Cancer Statistics Working Group"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0010","author":"Cancer Stat Facts: Vulvar Cancer"},{"issue":"26","key":"10.1016\/j.ygyno.2017.12.019_bb0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers - United States, 2008-2012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ygyno.2017.12.019_bb0020","author":"What Are the Key Statistics About Vulvar Cancer?"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0025","author":"What Are the Risk Factors?"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0030","author":"Vaginal and Vulvar Cancers Statistics"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0035","author":"Age-Adjusted Invasive Cancer Incidence Rates by Public Health Region in Texas, 2010\u20132014"},{"issue":"6","key":"10.1016\/j.ygyno.2017.12.019_bb0040","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2017.12.019_bb0045","author":"How Many Cancers Are Linked with HPV Each Year?"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0050","author":"HPV-Associated Cancer Diagnosis by Age"},{"issue":"5","key":"10.1016\/j.ygyno.2017.12.019_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.12.019_bb0060","article-title":"Prevalence of HPV in adults aged 18\u201369: United States, 2011\u20132014","volume":"280","author":"McQuillan","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"7","key":"10.1016\/j.ygyno.2017.12.019_bb0065","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob. Health"},{"issue":"33","key":"10.1016\/j.ygyno.2017.12.019_bb0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.15585\/mmwr.mm6533a4","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317years - United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2017.12.019_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2307\/2529981","article-title":"Bias reduction using Mahalanobis-metric matching","volume":"36","author":"Rubin","year":"1980","journal-title":"Biometrics"},{"issue":"6","key":"10.1016\/j.ygyno.2017.12.019_bb0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"Comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2014","journal-title":"Stat. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2017.12.019_bb0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","article-title":"Practical considerations on the use of the Charlson comorbidity index with administrative data bases","volume":"49","author":"D'Hoore","year":"1996","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.12.019_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00005650-198905000-00009","article-title":"A psychiatric patient classification system. An alternative to diagnosis-related groups","volume":"27","author":"Ashcraft","year":"1989","journal-title":"Med. Care"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0095","author":"Consumer Price Index-Medical Care"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0100","series-title":"Economic Evaluation in Clinical Trials New York","first-page":"96","article-title":"Analyzing cost","author":"Glick","year":"2014"},{"issue":"1","key":"10.1016\/j.ygyno.2017.12.019_bb0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygyno.2017.02.011","article-title":"Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas","volume":"145","author":"Lairson","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.12.019_bb0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2008.07.032","article-title":"Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan","volume":"111","author":"Insinga","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.019_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/1758-3284-4-15","article-title":"The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid","volume":"4","author":"Jacobson","year":"2012","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.ygyno.2017.12.019_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-12-1082","article-title":"Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark","volume":"12","author":"Olsen","year":"2012","journal-title":"BMC Public Health"},{"issue":"10 Suppl","key":"10.1016\/j.ygyno.2017.12.019_bb0125","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817316050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817316050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:58:52Z","timestamp":1535158732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817316050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0090825817316050"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}